
Number of publications published per year by Cramp, Matthew E.. (Source : PubMed)

Distribution of publications types for Cramp, Matthew E.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Limitations of the algorithm for the SAFE biopsy: a noninvasive fibrosis measure in chronic hepatitis C.
Hepatology
2010;51;1
Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.
Hepatology
2009

Elastography for the non-invasive assessment of liver disease: limitations and future developments.
Gut
2009;58;8
Hepatitis C virus (HCV)--specific T cell responses in injection drug users with apparent resistance to HCV infection.
J. Infect. Dis.
2008;198;12
Interleukin 12B gene polymorphism and apparent resistance to hepatitis C virus infection.
Clin. Exp. Immunol.
2008;152;3

Reactivation of latent hepatitis B virus infection with HIV-related immunosuppression.
Int J STD AIDS
2006;17;1
Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics.
J. Infect. Dis.
2005;192;7

Hepatic hydrothorax.
Br J Hosp Med (Lond)
2005;66;9
Screening for hepatitis C virus in the Dartmoor prison population: an observational study.
J Public Health (Oxf)
2004;26;4


HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.
Science
2004;305;5685
[ See timeline ] [ See all publications ]
means that Cramp, Matthew E. has 13 papers cited a least 13 times - methodology
Institute of Liver Studies, King's College Hospital, London, United Kingdom.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.